Risk factor analysis and risk assessment model development for Crohn's disease with metabolic dysfunction-associated fatty liver disease in a Chinese population
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Metabolic dysfunction-associated fatty liver disease (MASLD) frequently occurs as a hepatic complication in patients diagnosed with Crohn's disease (CD), influenced by numerous risk determinants. This study aimed to explore the clinical characteristics associated with MASLD in CD patients and to construct a tailored risk assessment model. Methods Patients with CD who were hospitalized at our gastroenterology unit between January 2021 and March 2025 were enrolled. Patients were divided into two groups based on hepatic ultrasonography, as well as cardiovascular metabolic risk assessment: MASLD and non-MASLD. Clinical variables, laboratory results, as well as histories of medication intake, were obtained for both groups. Putative risk factors were first identified in univariate analyses, further adjusted by least absolute shrinkage and selection operator (LASSO) regression. Multivariate logistic regression was finally performed to establish the risk assessment model, from which a nomogram was created. Model performance was assessed by the concordance index (C-index), calibration curve, and decision curve analysis (DCA). Internal validation was performed by bootstrap resampling (1,000 replicates) to obtain optimism-corrected performance estimates, Sensitivity analyses were performed to address incorporation bias. Result A total of 187 patients with CD were enrolled, among whom the MASLD prevalence was 20.9%. Multivariate logistic regression identified independent risk factors of MASLD, including age, body mass index (BMI), high-density lipoprotein (HDL), lactate dehydrogenase (LDH), and fecal calprotectin (FC). The model showed good discrimination for ultrasound-defined MASLD (C-index 0.915). The calibration curve demonstrated close correspondence between predicted probabilities and observed outcomes. Bootstrap validation yielded an optimism-corrected C-index of 0.900 (estimated optimism, 0.015), with an optimism-corrected calibration slope of 0.854 and intercept of −0.106, while DCA suggested potential net benefit across a wide threshold range. In sensitivity analyses, the model excluding BMI and HDL achieved an area under the receiver operating characteristic curve (AUC) of 0.804. Conclusion A nomogram incorporating age, BMI, HDL, LDH and FC showed promising performance in identifying ultrasound-defined MASLD in hospitalized Chinese patients with CD. External and prospective validation is required before the model can be used to guide further hepatic evaluation.
Source: Frontiers in Medicine
Authors: Xueyun Zhang(Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Keyu Jia(Formal analysis, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing), Ye Chen(Data curation, Writing – review & editing), Shiying Yuan(Data curation, Writing – review & editing), Jun Shen(Resources, Supervision, Writing – review & editing), Yuqi Qiao(Resources, Supervision, Writing – review & editing)
Institutions: Shanghai Jiao Tong University, Renji Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236490581
